These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29929464)

  • 1. Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles.
    Thomas SC; Madaan T; Iqbal Z; Talegaonkar S
    Curr Drug Deliv; 2018; 15(9):1230-1244. PubMed ID: 29929464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
    Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
    Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
    Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer.
    Dubey P; Gidwani B; Pandey R; Shukla SS
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1491-7. PubMed ID: 26134925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled PLGA Nanoparticles for Effective Targeting of Bendamustine in Tumor Bearing Mice.
    Khan I; Gothwal A; Kaul A; Mathur R; Mishra AK; Gupta U
    Pharm Res; 2018 Aug; 35(11):200. PubMed ID: 30171428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic.
    Gothwal A; Khan I; Kumar P; Raza K; Kaul A; Mishra AK; Gupta U
    Mol Pharm; 2018 Jun; 15(6):2084-2097. PubMed ID: 29195048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
    Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
    Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments.
    Simonoska Crcarevska M; Geskovski N; Calis S; Dimchevska S; Kuzmanovska S; Petruševski G; Kajdžanoska M; Ugarkovic S; Goracinova K
    Eur J Pharm Sci; 2013 Apr; 49(1):65-80. PubMed ID: 23439240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system.
    Tseng CL; Chen JC; Wu YC; Fang HW; Lin FH; Tang TP
    J Biomater Appl; 2015 Oct; 30(4):388-97. PubMed ID: 26069284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: Optimization, pharmacokinetic, cytotoxicity and in vivo assessments.
    Vardhan H; Mittal P; Adena SKR; Upadhyay M; Mishra B
    Int J Biol Macromol; 2017 Oct; 103():791-801. PubMed ID: 28536023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
    Girotra P; Singh SK
    AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB; Surana SJ
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
    Gajra B; Patel RR; Dalwadi C
    Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium oxide nanoparticle-loaded polycaprolactone composite electrospun fiber scaffolds for bone-soft tissue engineering applications: in-vitro and in-vivo evaluation.
    Suryavanshi A; Khanna K; Sindhu KR; Bellare J; Srivastava R
    Biomed Mater; 2017 Sep; 12(5):055011. PubMed ID: 28944766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.